ARTICLE | Company News
GeneMedicine deal
November 21, 1994 8:00 AM UTC
The Houston company and Vanderbilt University Medical Center will develop pulmonary gene therapy methods and will conduct a pulmonary gene therapy clinical trial. GMED will support pulmonary gene therapy research projects at Vanderbilt and will receive rights to gene therapy technologies developed at the Center for Lung Research. ...